However, the overall safety profile of taspoglutide was clearly worse than exenatide with respect to gastrointestinal tolerability, systemic allergic reactions, and injection-site reactions.

drug in development Taspoglutide Transient nausea Still unknown, drug in development Incretins, including glucagon-like peptide (GLP)-1, are peptide hormones responsible for the 'incretin effect ...